By Justin Petrone

CGC Genetics will launch a genetic test in the second quarter of 2011 designed to identify diabetes and obesity risk.

Based on the Illumina BeadXpress system, the assay will become the ninth test to be deployed on the platform, and more are expected, according to CGC CEO Puri Tavares.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.